tiprankstipranks
Trending News
More News >
Fulcrum Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe FlyFulcrum Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
24d ago
Oppenheimer biotech analyst holds an analyst/industry conference call
Premium
The Fly
Oppenheimer biotech analyst holds an analyst/industry conference call
1M ago
Cautious Outlook for Fulcrum Therapeutics Amid Phase 1b Progress and Enrollment Uncertainties
Premium
Ratings
Cautious Outlook for Fulcrum Therapeutics Amid Phase 1b Progress and Enrollment Uncertainties
1M ago
Fulcrum Therapeutics reports Q1 EPS (28c) vs. (43c) last year
PremiumThe FlyFulcrum Therapeutics reports Q1 EPS (28c) vs. (43c) last year
1M ago
Fulcrum Therapeutics sees cash runway into at least 2027
Premium
The Fly
Fulcrum Therapeutics sees cash runway into at least 2027
1M ago
Fulcrum Therapeutics Faces Termination of Key Agreement
Premium
Company Announcements
Fulcrum Therapeutics Faces Termination of Key Agreement
3M ago
Fulcrum Therapeutics Reports Strong Financial Position and Progress
PremiumCompany AnnouncementsFulcrum Therapeutics Reports Strong Financial Position and Progress
3M ago
OpCo reiterates Outperform on Fulcrum given bullish vibes ahead of SCD readout
Premium
The Fly
OpCo reiterates Outperform on Fulcrum given bullish vibes ahead of SCD readout
3M ago
Fulcrum Therapeutics reports Q4 EPS (31c), consensus (29c)
Premium
The Fly
Fulcrum Therapeutics reports Q4 EPS (31c), consensus (29c)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100